Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 2,583: | Line 2,583: | ||
|Astrocystoma, IDH-Mutant | |Astrocystoma, IDH-Mutant | ||
|Disease | |Disease | ||
|Riley Lochner (trainee), Shashi Shetty (mentor) | |||
|3/3/2022 | |||
| | | | ||
|PENDING | |||
| | | | ||
|Laveniya Satgunaseelan (LS) | |||
| | | | ||
| | |2021 template added | ||
|- | |- | ||
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease|| | |Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor) | ||
| | |3/3/2022 | ||
| | | | ||
|PENDING | |||
| | | | ||
|Laveniya Satgunaseelan (LS) | |||
| | | | ||
|2021 template added | |||
|- | |- | ||
|Glioblastoma, IDH-Wildtype||Disease|| | |Glioblastoma, IDH-Wildtype||Disease|| | ||
| Line 2,646: | Line 2,646: | ||
| | | | ||
|- | |- | ||
|Diffuse Midline Glioma, H3 K27-Altered||Disease|| | |Diffuse Midline Glioma, H3 K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version) | ||
| | | | ||
| | | | ||
|PENDING | |||
| | | | ||
|LS | |||
| | | | ||
|2021 template added | |||
|- | |- | ||
|Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease|| | |Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu | ||
| | |2/21/2022 | ||
| | | | ||
|PENDING | |||
| | | | ||
|LS | |||
| | | | ||
|2021 template added | |||
|- | |- | ||
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease|| | |Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova | ||
| | |10/28/2022 | ||
| | | | ||
|PENDING | |||
| | | | ||
|LS | |||
| | | | ||
|2021 template added | |||
|- | |- | ||
|Infant-Type Hemispheric Glioma||Disease|| | |Infant-Type Hemispheric Glioma||Disease|| | ||
| Line 2,680: | Line 2,680: | ||
| | | | ||
| | | | ||
| | |2021 template added | ||
|- | |- | ||
|Pilocytic Astrocytoma||Disease|| | |Pilocytic Astrocytoma||Disease||Jeremy Pulvers | ||
| | |9/13/2022<br /> | ||
| | | | ||
|PENDING | |||
| | | | ||
|LS | |||
| | | | ||
|2021 template added | |||
|- | |- | ||
|High-Grade Astrocytoma with Piloid Features||Disease|| | |High-Grade Astrocytoma with Piloid Features||Disease|| | ||
| Line 2,736: | Line 2,736: | ||
| | | | ||
|- | |- | ||
|Ganglioglioma||Disease|| | |Ganglioglioma||Disease||Leila Moayed-Aloei | ||
| | |6/30/2022 | ||
| | | | ||
|COMPLETE | |||
| | | | ||
|LS | |||
| | | | ||
|2021 template added | |||
|- | |- | ||
|Gangliocytoma||Disease|| | |Gangliocytoma||Disease|| | ||
| Line 2,979: | Line 2,979: | ||
| | | | ||
|- | |- | ||
|Medulloblastoma, WNT-Activated||Disease|| | |Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City | ||
| | |9/20/21 | ||
| | | | ||
|COMPLETE | |||
| | | | ||
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS) | |||
|9/22/2022 | |||
|2021 template added | |||
|- | |- | ||
|Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease|| | |Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease|| | ||